George Whitesides owns over 4,000 units of Theravance Biopharma Inc stock worth over $34,480 and over the last 8 years he sold TBPH stock worth over $0. Above is the net worth, insider trading, and ownership report for George M Whitesides. Gurus may be added or dropped from the GuruFocus site at any time. George M Whitesides is the director of AMAG Pharmaceuticals Inc. . NEXT ARTICLE. He is also a fellow of the American Association for the Advancement of Science and the American Philosophical Society. Its purpose is to pioneer a new generation of small molecule drugs designed to better meet patient needs. George Whitesides owns over 4,000 units of Theravance Biopharma Inc stock worth over $35,440 and over the last 8 years he sold TBPH stock worth over $0. The most-recent trade in Theravance Biopharma Inc is the Theravance Biopharma Inc executives and other stock owners filed with the SEC include: Track performance, allocation, dividends, and risks, Annotate, download XLSX & look up similar tables, Filter, compare, and track coins & tokens, Stocks and cryptocurrency portfolio tracker. A design (with diameters of channels 20 m) is created in a From 1986 to 2004, Dr. Whitesides was Mallinckrodt Professor of Chemistry at Harvard University. PREVIOUS ARTICLE. Other transactions such as conversion of derivative security or exercise of options are not included. . sale This work has become a basis for developments in nanoscience, electronics, pharmaceutical science and medical diagnostics. Dr. George M. Whitesides Ph.D. serves as Independent Director of the Company., serves as an Independent Director of Company. Whitesides has worked on advisory committees for the National Science Foundation known as NASA and the Department of Defense. a net He went on to earn his Ph.D. in chemistry from Cal Tech in 1964. [8], Last edited on 27 February 2023, at 16:51, Publishing Your Research 101 Impact of technology on scientific articles, Talking Nano: Perspectives on Nanotechnology (1 of 4), The Courage to Go Off and Start New Things, American Association for the Advancement of Science, Royal Netherlands Academy of Arts and Sciences, F. A. Its purpose is to pioneer a new generation of small molecule drugs designed to better meet patient needs. History at Harvard University is noted for its diversity, creativity, and productivity, and for the quality of the students, it produces. In 1963 Whitesides began his independent career as an assistant professor at the Massachusetts Institute of Technology, remaining there till 1982. of 0 shares. which makes cover-to-cover reading a slightly exhausting experiencebut worth it when it rewards the reader with such gems as why young children at a party behave like cellular molecules, or . Interim CFO Brian Piekos Cotton Medal for Excellence in Chemical Research of the American Chemical Society in 2011. 6 Body Measurements: Height, Weight, Hair Color. 2 Family, Parents, Siblings, Education. Prior to our spin-off from Innoviva in June 2014 and since the inception of Innoviva in 1996, Dr. Whitesides served as a director of Innoviva. North Carolina State: The Wolfpack is 41 st in the NET. There are 1 older and 26 younger executives at Theravance Biopharma Inc. George Whitesides owns over 4,000 units of Theravance Biopharma Inc stock worth over $40,260 and over the last 9 years he sold TBPH stock worth over $0. degree from Harvard University in 1960 and a Ph.D. from the California Institute of Technology (with J.D. George M Whitesides Net Worth 2022 and insider trades. George M. Whitesides (b. August 3 1939 Louisville Kentucky) is an American chemist and professor of chemistry at Harvard University. George Whitesides owns over 4,000 units of Theravance Biopharma Inc stock worth over $37,800 and over the last 8 years he sold TBPH stock worth over $0. of 65,000 shares made by Andrew A. Hindman George M Whitesides is the director of Theravance Biopharma Inc. and Shola Shoretire is a well-known English professional footballer. The estimated Net Worth of George M Whitesides is at least $372 Thousand dollars as of 11 August 2017. He now . "[16], Whitesides' interests include "physical and organic chemistry, materials science, biophysics, complexity and emergence, surface science, microfluidics, optics, self-assembly, micro- and nanotechnology, science for developing economies, molecular electronics, catalysis, energy production and conservation, origin of life, rational drug design, cell-surface biochemistry, simplicity, and infochemistry. Verified email at gmwgroup.harvard.edu - Homepage. . Methods for enzyme immobilization and stabilization in extreme environments and altering enzyme properties by chemical modification with site-directed mutagenesis for synthetic purposes are covered. George Whitesides, then CEO of Virgin Galactic, demonstrated sustained leadership in. George M Whitesides is the director of Innoviva Inc. , Roberts) in 1964. His first appointment was in the chemistry department at MIT. 10 percent owner Weiss Asset Management Lp According to the SEC Form 4 filings, George M Whitesides has made a total of His lab work that focuses on materials science involves the fabrication of nanostructures, microfluidic systems, microelectromechanical systems, and 3-D microstructures. Addressing human, financial, and informational issues, the report argued in favor of:[27], In 2002, Whitesides served as the Chairman of the International Review Panel that evaluated the state of chemical research in the United Kingdom. purchase [3] He studied in Newton North High School. University of Science & Technology of China. Saint Marys, GA. of 0 shares. [30] He is also a member of the Reliance Innovation Council formed by Reliance Industries Limited, India. [2] At Caltech, Whitesides began working in organic chemistry. Park. Bushwick Bill (Richard Stephen Shaw) is an American-Jamaican rapper best known as a member of the pioneering Texas hip hop group Geto Boys, BY Tabloid June 9, 2019. Other key executives at Lyra Therapeutics Inc include In summary, during the past 3 months, insiders sold 50,000 shares of Theravance Biopharma Inc (TBPH) in total and bought 0 shares, with a net CEO of La Jolla Pharmaceutical Larry G. Edwards Lyra Therapeutics Inc (LYRA)'s detailed insider trading history can be found in Insider Trading Tracker table. See speaker profile. George M. Whitesides , Past performance is a poor indicator of future performance. Theravance Biopharma Inc (TBPH) Though Whitesides had never heard of that school and recalled that he was unknown where New England was, he agreed to go. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. 1964 (Caltech . The estimated net worth of George M Whitesides is at least $2 Million dollars as of 2023-03-04. Identities Podcasts. Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Innoviva Inc (INVA)'s detailed insider trading history can be found in Insider Trading Tracker table. 0 transactions in Theravance Biopharma Inc (TBPH) over the past 5 years. George Whitesides is 80, he's been the Independent Director of Theravance Biopharma Inc since 2013. 5 Relationship, Married, Affair. He has also served on the National Research Council in various capacities since 1984, including stints on the Committee on Science and Technology for Counter Terrorism and the Committee on Nanotechnology for the Intelligence Community. degree from Harvard University in 1960 and a Ph.D. from the California Institute of Technology (with J.D. of 7,828 shares made by C Ann Merrifield pulling together NASA Armstrong and local aerospace engineering capacity to address. You can see the complete history of George Whitesides stock trades at the bottom of the page. . DOI: 10.1126/science.256.5063.1539. These companies include Genzyme, GelTex, Theravance, Surface Logix, Nano Terra, and WMR Biomedical. A native of Kentucky, Whitesides earned a bachelors degree from Harvard in 1960 and 1964 with his advisor John D. Roberts (a fellow NMS recipient), a doctorate in chemistry from the California Institute of Technology. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. [37] According to the Hirsch index, a ranking which combines number of articles published and citations of those articles by others, he was the most influential living chemist in 2011. Chief Executive Officer Pavel Raifeld a net In addition, he makes $337,879 as Independent Director at Theravance Biopharma Inc. . Stock quotes provided by InterActive Data. [8] Whitesides and his research group have made significant contributions by developing techniques for soft lithography and microcontact printing. George T. Whitesides net worth. George M Whitesides is George M Whitesides made purchase From 1982 to 1991 he was a member of the Department of Chemistry at Harvard University and Chairman of the Department of Chemistry from 1986 to 1989. director & Executive Chair Harlan Waksal Please only use it for a guidance and George T. Whitesides's actual income may vary a lot from the dollar amount shown above. George M. Whitesides was born August 3, 1939 in Louisville, KY. The largest trade he's ever made was buying 4,000 units of Theravance Biopharma Inc stock on 11 August 2017 worth over $98,760. [24], Whitesides is also known for publishing his "outline system" for writing scientific papers. You might contact George M Whitesides via mailing address: C/o Advanced Magnetics Inc, 61 Mooney Street, Cambridge Ma 02138. no insider transaction in Theravance Biopharma Inc (TBPH). In addition, he makes $337,879 as Independent Director at Theravance Biopharma Inc. To know more about George M Whitesides visit Hollywoodsbio.com. director & Executive Chair Harlan Waksal American chemist and professor of chemistryWhitesides is currently 81 years and running. During the past 18 months, 0 shares of Lyra Therapeutics Inc (LYRA) were sold and 11,026,781 shares were bought by its insiders, resulting in a net of 0 shares. . of 11,026,781 shares. [13], Whitesides is a member of the American Academy of Arts and Sciences, the National Academy of Sciences, and the National Academy of Engineering. Perosonal Details . Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The company recently received Food and Drug Administration approval for Feraheme, a novel iron replacement drug for CKD patients suffering from anemia, and also offers GastroMARK, an imaging aid used with magnetic resonance imaging. Jeff Foust March 5, 2021. 2004-2023 GuruFocus.com, LLC. and plans to travel to space as a "Founder Astronaut" on Virgin Galactic's SpaceShipTwo with her husband George T. Whitesides.Whitesides received a bachelor's degree in biology from Stanford and a master's from Caltech . , One of Whitesides teachers requested him the note his unique interests as well as his abilities. Ben Whitesides is the lead singer and the songwriter of The Joggers, a rock band based in Portland, Oregon. Theravance Biopharma Inc executives and other stock owners filed with the SEC include: Track performance, allocation, dividends, and risks, Annotate, download XLSX & look up similar tables, Filter, compare, and track coins & tokens. Both microscale and nanoscale techniques are based on printing, molding and embossing, and can be used for the fabrication of patterns and features on many different materials. Enjoy a 7-Day Free Trial Thru Mar 11, 2023! Being the son of a chemical engineer, he was exposed to science from a young age. He is particularly well known for his work in materials and surface science. Scientific Advisory Boards (2010 - present): MC-10, Sun Catalyix, Reliance Corporation (India, 2009-2016); NextGen Jane (2014- ); Breakthrough Energy Ventures (2017 -); Jana Care (2017 -)Boards of Directors (2000 - present; *= current)Genzyme (co-founder), Rohm and Haas, Dexter, Hughes Research Laboratory, Advanced Magnetics, Assemblon, Concurrent Biomedical, Theravance*, Theravance Biopharma*, Surface Logix, Nano-Terra (Founder)*, Arsenal Vascular*, Lyra Therapeutics* Diagnostics for All (501-c-3, Founder)*, MC 10 Corporation, Soft Robotics (Founder)*Editorial BoardsAngewandte Chemie, Langmuir, Small, Lab on a Chip, Soft Robotics.Research InterestsChemistry, materials science, biophysics, the role of water in biomolecular recognition, the hydrophobic effect, complexity and emergence, surface science, microfluidics, paper as a material, self-assembly, micro- and nanotechnology, healthcare for developing economies, catalysis, origin of life, dissipatice systems, soft robotics, rational drug design, simplicity, and infochemistry. sale The report addressed U.S. competitiveness in science and technology. , "[8] The article sparked strong reactions both for and against their ideas. Over the past 18 months, [9] Collaborations with biologists at MIT were an early influence informing his later work with biological systems. Based on ownership reports from SEC filings, as the reporting owner, George M Whitesides owns 4 companies in total, including FAQ: What is George Whitesides networth in 2020? From 2004 to 2008, Whitesides served as the Executive Director of the National Space Society. Identities Podcasts People Ai. 4 Awards and Nominations. Theravance Biopharma Inc (TBPH)'s detailed insider trading history can be found in Insider Trading Tracker table. a net George M Whitesides is the director of Lyra Therapeutics Inc. [20][21] Such techniques have now become standard in the field. of 0 shares. of 0 shares. of 2,488,150 shares made by Edward T Anderson Vol 256, Issue 5063. pp. [8][50], More recently, George Whitesides received the 2009 Dreyfus Prize in the Chemical Sciences from The Camille and Henry Dreyfus Foundation on September 30, 2009, for his creation of new materials that have significantly advanced the field of chemistry and its societal benefits. One of Whitesides' teachers took note of his unique interests and abilities and recommended that his parents send him to Phillips Academy Andover . We share information about different celebrities, Biography of scientists, inventor etc. [52], He received the Othmer Gold Medal for outstanding contributions to progress in chemistry and science in 2010. Whitesides' demonstrated leadership in his field, his knowledge of scientific matters affecting our business and his understanding of our industry contributed to our board's conclusion that he should serve as a director. from Harvard University. During the past 18 months, 0 shares of AMAG Pharmaceuticals Inc (AMAG) were sold and 0 shares were bought by its insiders, resulting in a net Knowles. Provides CEO, CFO, Director and Chief Executives trade reports, independent equity research, and stock screening. sale and 1100+100040. , . of Lyra Therapeutics Inc (LYRA)'s detailed insider trading history can be found in Insider Trading Tracker table. . [4] He is the co-creator of Yuri's Night. [26] In 2002 he became foreign member of the Royal Netherlands Academy of Arts and Sciences. George M Whitesides is the director of Lyra Therapeutics Inc. Bushwick Bill Bio, Age, Height, Wife, Kids, Cancer, Death, Net Worth. He was part of the Committee on Science, Engineering, and Public Policy, which authored the National Academies' report Rising Above the Gathering Storm (2007). , George T. Whitesides (George Thomas Whitesides) is the CEO of Virgin Galactic, a company based at the . [35] He ranked 5th on Thomson ISI's list of the 1000 most cited chemists from 1981 to 1997,[36] and 38th on the list from 2000 to 2010. Being the son of a chemical engineer, he was exposed to science from a young age. of 0 shares. , 1999; This paper describes a procedure for rapidly and conveniently prototyping microfluidic devices that are useful with aqueous solutions. SVP & Chief Financial Officer Aziz Sawaf Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. The estimated Net Worth of George M Whitesides is at least $372 Tysic dollars as of 11 August 2017. Science. and "[11] He has shifted to new research areas many times throughout his career, averaging about ten years in any particular area. The company's technology platform, XTreo, is designed to precisely and consistently deliver medicines directly to the affected tissue for sustained periods with a single administration. George M Whitesides. He is also a member of the board of directors of Nano Terra Inc., Arsenal Biomedical, Inc., Lyra Biomedical, Inc., Diagnostics for All, Inc. and Soft Robotics Inc. Dr. Whitesides holds a Ph.D. in Chemistry from the California Institute of Technology and a B.A. George Whitesides owns over 4,000 units of Theravance Biopharma Inc stock worth over $40,280 and over the last 9 years he sold TBPH stock worth over $0. In addition, he makes $337,879 as Independent Director at Theravance Biopharma Inc. . , George Whitesides owns over 4,000 units of Theravance Biopharma Inc stock worth over $34,480 and over the last 8 years he sold TBPH stock worth over $0. GuruFocus tracks the stock performance after each of George M Whitesides's buying transactions within different timeframes. Research and Inventions of George M Whitesides have worked in an unusually broad range of areas, including organometallic chemistry, nuclear magnetic resonance (NMR) spectroscopy, applied enzymology, self-assembly, soft lithography, microfluidics, organic surface science, and nanotechnology. Whitesides has worked as Chairman of the Chemistry Department at Harvard University from 198689 in Associate Dean of the Faculty of Art and Science from 19891992. 557,455 views | George Whitesides TEDxBoston 2009. [32], Whitesides is the author of more than 1200 scientific articles[13] and is listed as an inventor on at least 134 patents. Whitesides has co-founded a nonprofit called Diagnostics for all, which aims to provide healthcare in a world where the cost is very key. During the past 18 months, 140,513 shares of Theravance Biopharma Inc (TBPH) were sold and 0 shares were bought by its insiders, resulting in a net (George McClelland Whitesides, 193983-) . [31], In an article in Nature (2011), Whitesides and John M. Deutch challenged the scientific and chemical communities to become more relevant to current social and environmental issues. Most recently he bought 4,000 units of TBPH stock worth $98,760 on 11 August 2017. 2020-21 Jimmy Murphy Young Player of the Year. Slow Crack Growth in Single-Crystal Silicon. The oldest executive at Theravance Biopharma Inc is BurtonMalkiel, 87, who is the Independent Director. To be detailed, the average return of stocks after 3 months bought by George M Whitesides is 19.38%. He studied in Newton North High School.Whitesides was previously Chief of Staff of the National Aeronautics and Space . He has been Woodford L. and Ann A. All Rights Reserved. Theravance Biopharma, Inc. is a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines. 1539-1541. As of 11 August 2017 he still owns at least 4,000 units of Theravance Biopharma Inc stock. The estimated Net Worth of George M Whitesides is at least $379 dollars as of 11 August 2017. Learn about George M. Whitesides Net Worth, Biography, Age, Birthday, Height, Early Life, Family, Dating, Partner, Wiki, and Facts. Whitesides announced his candidacy for the House of Representatives seat for California's 27th district on Wednesday. Advisory Positions (1980 - present)National Research Council: Board on Chemical Sciences and Technology (1984-89; Chairman, 1986-99); Naval Studies Board (1989-97; Vice Chairman, 1992-97); Committee on Bioprocess Engineering (1991-92); Board on Science, Technology and Economic Policy (1991-97); Visiting Committee to NIST/ATP on Advanced Technology (1994-97); Board on Physics and Astronomy (1997-2001) Committee on Science and Technology for Counter Terrorism (2002); Committee on Nanotechnology for the Intelligence Community (2003); Committee on Prospering in a Global Economy (the "Gathering Storm" Committee, 2005); Committee on Science, Engineering and Public Policy (COSEPUP, 2005-2013, Chairman); Committee on Forefronts of Science at the Interface of Physical and Life Sciences (2007-08); Committee on Determining Core Capabilities in Chemical and Biological Defense Research and Development (Advisor, 2012);National Science Foundation: Chemistry Advisory Committee (1984-86; Chairman, 1986), Materials Research Advisory Committee (1991-93; Chairman, 1993), Review Panel for the Materials Research Laboratories (1993, co-Chairman); Advisory Committee for Mathematics and Physical Sciences (1993-96); NSF Senior Assessment Panel: International Assessment of U. S. Mathematical Sciences (1997); Workshop on Chemical Bonding Centers, (2003); Workshop on Chemistry and Cognition (2004); NBIC/Convergence Committee (Chairman, 2012)Department of Defense: Defense Advanced Research Projects Agency Defense Science Research Council (1984-2013); Defense Science Board (1993-2003); Threat Reduction Advisory Committee to the Defense Threat Reduction Agency (1998- 2006); Defense Science Board Task Force on Deterring Weapons of Mass Destruction (2015-)National Aeronautics and Space Administration (NASA): Biological and Physical Research Maximization and Prioritization (REMAP) Task Force (2002).Other: M.I.T. Other recent insider transactions involving Theravance Biopharma Inc (TBPH) include Easy Navigation. community, national, and . among others If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. Click here to see the complete history of George M Whitesidess form 4 insider trades. Langer. Flowers University Professor at Harvard,[14] one of only 24 University Professorships at the institution as of 2014. Whitesides is active in multiple public service roles. , . , Disclamer: George T. Whitesides net worth displayed here are calculated based on a combination social factors. George T. Whitesides Wife. In addition, he makes $337,879 as Independent Director at Theravance Biopharma Inc. . Dr. George M. Whitesides Ph.D. serves as Independent Director of the Company., serves as an Independent Director of Company. He stands 6 feet 2 inches (1.88 m) tall, weighs 220 pounds (100 kg). Whitesides Current research interests include physical and organic chemistry, complexity and simplicity, materials science, biophysics, technology for developing economies, biology tools, and lifes origin. [4][5][6], Whitesides attended secondary school at Phillips Andover and graduated in 1957. Prior to our spin-off from Innoviva in June 2014 and since the inception of Innoviva in 1996, Dr. Whitesides served as a director of Innoviva. Establishing an author of nearly more than 1200, Whitesides has established scientific articles, which was later listed as an originator on nearly 134 franchises. Dr. Whitesides was a 1998 recipient of the National Medal of Science. [19], Early work by Ralph G. Nuzzo and David L. Allara on spontaneously organized molecular assemblies informed Whitesides' work on soft lithography.